[1]叶伟东,纪建松,涂建飞,等.氩氦刀冷冻消融联合肝动脉栓塞化疗术治疗中晚期肝癌的疗效分析[J].介入放射学杂志,2015,(05):392-395.
 YE Wei dong,JI Jian song,TU Jian fei,et al.Argon helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma: analysis of therapeutic effectiveness[J].journal interventional radiology,2015,(05):392-395.
点击复制

氩氦刀冷冻消融联合肝动脉栓塞化疗术治疗中晚期肝癌的疗效分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年05期
页码:
392-395
栏目:
肿瘤介入
出版日期:
2015-05-25

文章信息/Info

Title:
Argon helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma: analysis of therapeutic effectiveness
作者:
叶伟东 纪建松 涂建飞 虞作春 杨 杰
Author(s):
YE Wei dong JI Jian song TU Jian fei YU Zuo chun YANG Jie
Department of Infectious Diseases, Lishui Municipal Central Hospital, Zhejiang University, Lishui, Zhejiang Province 323000, China
关键词:
【关键词】 肝肿瘤 冷冻消融 TACE 疗效
文献标志码:
A
摘要:
【摘要】 目的 评价氩氦刀冷冻消融联合肝动脉栓塞化疗术(TACE)对中晚期原发性肝癌的疗效。方法 回顾性分析66例临床或病理确诊原发性肝癌患者的临床资料,根据治疗方式分为TACE组31例,联合组(冷冻消融联合TACE)35例,随访时间5~35个月,通过评估完全缓解率、总有效率及生存时间等方面来比较2种方法的近、远期疗效。结果 2组比较,在总有效率、完全缓解率方面,联合组均优于TACE组(P<0.05),联合组生存期长于TACE组(P=0.038)。在0.5年、1年、2年总体生存率方面,联合组与TACE组相比,差异无统计学意义。结论 对于中晚期原发性肝癌,冷冻消融联合TACE治疗能提高患者近期疗效并延长生存期,但确切效果还有待大样本、多中心随机对照研究证实。

参考文献/References:

[1] Baust JG, Gage AA, Clarke D, et al. Cryosurgery—a putative approach to molecular based optimization[J]. Cryobiology, 2004, 48: 190 204.
[2] Littrup PJ, Jallad B, Chandiwala Mody P, et al. Cryotherapy for breast cancer: a feasibility study without excision[J]. J Vasc Interv Radiol, 2009, 20: 1329 1341.
[3] Sidana A, Chowdhury WH, Fuchs EJ, et al. Cryoimmunotherapy in urologic oncology[J]. Urology, 2010, 75: 1009 1014.
[4] Marelli L, Stigliano R, Triantos C, et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies[J]. Cancer Treat Rev, 2006, 32: 594 606.
[5] Boerman OC, Koppe MJ, Postema EJ, et al. Radionuclide therapy of cancer with radiolabeled antibodies[J]. Anticancer Agents Med Chem, 2007, 7: 335 343.
[6] 孙 燕, 周际昌. 临床肿瘤内科手册[M]. 4版. 北京: 人民卫生出版社, 2003: 97 113.
[7] 吴孟超, 陈 汉, 沈 锋, 等. 微创在肝癌外科治疗中的地位[J]. 中国微创外科杂志, 2002, 2: 69 70.
[8] Ravindranath MH, Wood TF, Soh D, et al. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM[J]. Cryobiology, 2002, 45: 10 21.
[9] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版)[J]. 临床肝胆病杂志, 2011: 1141 1159.
[10] Clavien PA, Kang KJ, Selzner N, et al. Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis[J]. J Gastrointest Surg, 2002, 6: 95 101.
[11]黄 斌, 周 石. TACE联合氩氦刀冷冻术治疗巨块型肝细胞癌的临床研究[J]. 介入放射学杂志, 2011, 20: 28 31.
[12]周怡婷, 曹建民, 许 健, 等. 氩氦刀联合栓塞化疗治疗中晚期肝癌的临床研究[J]. 介入放射学杂志, 2009, 18: 733 736.
[13] 侯晓玮, 宋 谦, 李露嘉, 等. TACE联合氩氦冷冻消融治疗原发性肝癌效果观察[J]. 实用医药杂志, 2013, 30: 293 295.
[14] 刘秋华, 周萃阶, 张 伯, 等. TACE联合氩氦刀冷冻治疗原发性肝癌临床分析[J]. 肝胆胰外科杂志, 2014, 26: 278 280.

相似文献/References:

[1]叶 萍,常兆华,韩宝三.乳腺肿瘤冷冻消融治疗的研究进展[J].介入放射学杂志,2011,(08):660.
 YE Ping,CHANG Zhao-hua,HAN bao-san.Research progress in cryoablation therapy for breast tumor[J].journal interventional radiology,2011,(05):660.
[2]杜 鲲,管 生,胡小波,等. 原发性肝癌TACE术后完全缓解病灶磁共振 ADC值可重复性及一致性研究[J].介入放射学杂志,2011,(11):867.
 DU Kun,GUAN Sheng,HU Xiao-bo,et al.Magnetic resonance apparent diffusion coefficient values of the completely remitted lesions of primary hepatocellular carcinoma after TACE: a study of their repeatability and consistency[J].journal interventional radiology,2011,(05):867.
[3]李建军,郑加生,崔雄伟,等. 肝肿瘤CT引导经皮射频消融术后胆道并发症防治[J].介入放射学杂志,2011,(12):984.
 LI Jian-jun,ZHENG Jia-sheng,CUI Xiong-wei,et al.The prevention and treatment of biliary complications occurred after CT-guided percutaneous radiofrequency ablation for hepatic neoplasms[J].journal interventional radiology,2011,(05):984.
[4]张学彬,花迎雪,仇晓霞,等. 肝动脉臭氧化碘油栓塞治疗兔VX2肝癌的初步研究[J].介入放射学杂志,2012,(09):760.
 ZHANG Xue- bin,HUA Ying-xue,QIU Xiao- xia,et al. A preliminary study of hepatic arterial embolization with ozonated?蛳 Lipiodol for liver VX2 carcinoma in experimental rabbits[J].journal interventional radiology,2012,(05):760.
[5]刘长富,郭 志,司同国,等. 高迁移率族蛋白B1对激素难治性前列腺癌冷冻免疫反应的影响[J].介入放射学杂志,2013,(06):494.
 LIU Chang? fu,GUO Zhi,SI Tong? guo,et al. The effect of high mobility group protein B1 on cryoimmunologic reaction in hormone?蛳 refractory prostate cancer: an experimental study in rats[J].journal interventional radiology,2013,(05):494.
[6]韩宗宏,史东宏,许 健,等.氩氦刀联合动脉化疗栓塞治疗16例肾上腺恶性肿瘤[J].介入放射学杂志,2013,(07):553.
 HAN Zong? hong,SHI Dong? hong,XU Jian,et al.Argon?蛳 helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of malignant adrenal neoplasms: initial experience in 16 cases[J].journal interventional radiology,2013,(05):553.
[7]钱 亭,陈茂振,高 峰,等. 两种方法建立兔VX2肝癌模型的比较及影像学评估[J].介入放射学杂志,2014,(01):58.
 QIAN Ting,CHEN Mao? zhen,GAO Feng,et al. Comparison of two methods used in establishing VX?蛳 2 liver tumor model in rabbits and their imaging evaluation[J].journal interventional radiology,2014,(05):58.
[8]徐守军,杜端明,刘鹏程,等. 肝肿瘤射频消融术后CT表现及其临床意义[J].介入放射学杂志,2014,(01):69.
 XU Shou? jun,DU Duan? ming,LIU Peng? cheng,et al. CT manifestation and its clinical significance of liver tumors after radiofrequency ablation[J].journal interventional radiology,2014,(05):69.
[9]陈文会,杨朝爱,杨继金,等. 曲马多在经皮穿刺肝肿瘤射频消融术中的应用[J].介入放射学杂志,2014,(02):126.
 CHEN Wen? hui,YANG Chao? ai,YANG Ji? jin,et al. Application of tramadol in performing percutaneous radiofrequency ablation for liver neoplasms[J].journal interventional radiology,2014,(05):126.
[10]陈长广,倪才方,陈 珑. 肝动脉栓塞联合射频消融对兔肝癌模型VEGF及MVD的影响[J].介入放射学杂志,2013,(11):936.
 CHEN Chang? guang,NI Cai? fang,CHEN Long.. Effect of transcatheter arterial chemoembolization together with radiofrequency ablation on VEGF and MVD in rabbit models with hepatic cancer[J].journal interventional radiology,2013,(05):936.

备注/Memo

备注/Memo:
(收稿日期:2014-08-15)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-05-19